Thinking about the Development of Rapid Recommendation Based on the Status of COVID-19 Evidence

ZENG Li'nan; ZHANG Lingli

doi:10.12290/xhyxzz.2021-0280

Volume 12 Issue 4

Jul. 2021

Turn off MathJax

Article Contents

Abstract

References

Medical Journal of Peking Union Medical College Hospital > 2021 > 12(4): 544-551. > DOI: 10.12290/xhyxzz.2021-0280

ZENG Li'nan, ZHANG Lingli. Thinking about the Development of Rapid Recommendation Based on the Status of COVID-19 Evidence[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 544-551. DOI: 10.12290/xhyxzz.2021-0280

Citation:

PDF (1285 KB)

Thinking about the Development of Rapid Recommendation Based on the Status of COVID-19 Evidence

ZENG Li'nan^{1, 2, 3, 4},
ZHANG Lingli^{1, 2, 3, ,}

1.
Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, China
2.
Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China
3.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, China
4.
MAGIC, Oslo, Norway, N-0130

Funds:

Science and Technology Plan Project of Sichuan Province 2020YFS0035

Subproject of Science and Technology Plan Project of Sichuan Province 20ZDYF3101

More Information

Corresponding author:
ZHANG Lingli Tel：86-28-85503205，E-mail：zhanglingli@scu.edu.cn
Received Date: March 23, 2021
Accepted Date: May 20, 2021
Available Online: June 28, 2021
Issue Publish Date: July 29, 2021

Graphical Abstract

Abstract

Abstract

With the outbreak and rapid spread of the COVID-19 worldwide, a large amount of relevant research evidence has quickly emerged. However, due to the uneven quality of evidence, poor quality and slow speed of evidence translation, it is a big challenge for health decision-makers, clinicians, and patients to make evidence-based decisions. Based on rapid systematic review of evidence, the rapid advice-guidelines can promptly and effectively transform the latest current evidence into recommendations guiding clinical practice. In the face of global public health emergencies, by building a new type of evidence ecosystem, a completely closed loop of evidence from production and evaluation to application and transformation is formed to improve the level of medical practice and reduce the waste of health resources.
- coronavirus disease 2019,
- rapid advice guidelines,
- evidence-based decision

FullText(HTML)

References (55)

References

[1]	World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard[EB/OL ]. (2020-12-09)[2020-12-09]. https://covid19.who.int/.
[2]	Centers for Disease Control and Prevention. Coronavirus (COVID-19)[EB/OL]. (2020-12-08)[2020-12-09]. https://www.cdc.gov/coronavirus/2019-ncov/index.html.
[3]	European Centre for Disease Prevention and Control. COVID-19 pandemic[EB/OL ]. (2020-12-08)[2020-12-09]. https://www.ecdc.europa.eu/en/COVID-19-pandemic.
[4]	Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence[J]. Lancet, 2009, 374: 86-89. DOI: 10.1016/S0140-6736(09)60329-9
[5]	Glasziou PP, Sanders S, Hoffmann T. Waste in COVID-19 research[J]. BMJ, 2020, 369: m1847. http://www.bmj.com/content/369/bmj.m1847/rr-8
[6]	Budhathoki P, Shrestha DB, Rawal E, et al. Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis[J]. SN Compr Clin Med, 2020, 19: 1-21. DOI: 10.1007/s42399-020-00515-6
[7]	Cano EJ, Fonseca Fuentes X, Corsini Campioli C, et al. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis[J]. Chest, 2021, 159: 1019-1040. DOI: 10.1016/j.chest.2020.10.054
[8]	Cheng WW, Li YF, Cui LY, et al. Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis[J]. Front Pharmacol, 2020, 11: 571156. DOI: 10.3389/fphar.2020.571156
[9]	Halpin DMG, Singh D, Hadfield RM. Inhaled corticos-teroids and COVID-19: a systematic review and clinical perspective[J]. Eur Respir J, 2020, 55: 2001009. DOI: 10.1183/13993003.01009-2020
[10]	Lee KH, Yoon S, Jeong GH, et al. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2020, 9: 2392. DOI: 10.3390/jcm9082392
[11]	Li H, Chen CX, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis[J]. Leukemia, 2020, 34: 1503-1511. DOI: 10.1038/s41375-020-0848-3
[12]	Shuto H, Komiya K, Yamasue M, et al. A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19[J]. Sci Rep, 2020, 10: 20935. DOI: 10.1038/s41598-020-78054-2
[13]	Singh AK, Majumdar S, Singh R, et al. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective[J]. Diabetes Metab Syndr, 2020, 14: 971-978. DOI: 10.1016/j.dsx.2020.06.054
[14]	Sterne JAC, Diaz J, Villar J, et al. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials[J]. Trials, 2020, 21: 734. DOI: 10.1186/s13063-020-04641-3
[15]	Tlayjeh H, Mhish OH, Enani MA, et al. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis[J]. J Infect Public Health, 2020, 13: 1652-1663. DOI: 10.1016/j.jiph.2020.09.008
[16]	Veronese N, Demurtas J, Yang L, et al. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature[J]. Front Med (Lausanne), 2020, 7: 170. http://www.researchgate.net/publication/340628790_Use_of_Corticosteroids_in_Coronavirus_Disease_2019_Pneumonia_A_Systematic_Review_of_the_Literature
[17]	Yang ZW, Liu JL, Zhou YJ, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis[J]. J Infect, 2020, 81: e13-e20. http://www.sciencedirect.com/science/article/pii/S0163445320301912?via%3Dihub
[18]	Ye Z, Wang Y, Colunga-Lozano LE, et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis[J]. CMAJ, 2020, 192: E756-E767. DOI: 10.1503/cmaj.200645
[19]	Sharma SK, Mishra M, Mudgal SK. Efficacy of cloth face mask in prevention of novel coronavirus infection transmis-sion: A systematic review and meta-analysis[J]. J Educ Health Promot, 2020, 9: 192. DOI: 10.4103/jehp.jehp_533_20
[20]	Long Y, Hu T, Liu L, et al. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis[J]. J Evid Based Med, 2020, 13: 93-101. DOI: 10.1111/jebm.12381
[21]	Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis[J]. Travel Med Infect Dis, 2020, 36: 101751. DOI: 10.1016/j.tmaid.2020.101751
[22]	Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses[J]. Cochrane Database Syst Rev, 2020(11): CD006207.
[23]	Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis[J]. Lancet, 2020, 395: 1973-1987. DOI: 10.1016/S0140-6736(20)31142-9
[24]	Camargo MC, Martinez-Silveira MS, Lima AA, et al. Effectiveness of the use of non-woven face mask to prevent coronavirus infections in the general population: a rapid systematic review[J]. Cien Saude Colet, 2020, 25: 3365-3376. DOI: 10.1590/1413-81232020259.13622020
[25]	Brainard J, Jones NR, Lake IR, et al. Community use of face masks and similar barriers to prevent respiratory illness such as COVID-19: a rapid scoping review[J]. Euro Surveill, 2020, 25: 2000725.
[26]	Aggarwal N, Dwarakanathan V, Gautam N, et al. Facemasks for prevention of viral respiratory infections in community settings: A systematic review and meta-analysis[J]. Indian J Public Health, 2020, 64: S192-S200. DOI: 10.4103/ijph.IJPH_470_20
[27]	Casigliani V, De Nard F, De Vita E, et al. Too much information, too little evidence: is waste in research fuelling the COVID-19 infodemic?[J]. BMJ, 2020, 370: m2672. http://www.bmj.com/content/370/bmj.m2672
[28]	Landhuis E. Scientific literature: Information overload[J]. Nature, 2016, 535: 457-458. DOI: 10.1038/nj7612-457a
[29]	Sampson M, Shojania KG, Garritty C, et al. Systematic reviews can be produced and published faster[J]. J Clin Epidemiol, 2008, 61: 531-536. DOI: 10.1016/j.jclinepi.2008.02.004
[30]	Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap[J]. PLoS Med, 2014, 11: e1001603. DOI: 10.1371/journal.pmed.1001603
[31]	Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals[J]. JAMA, 1998, 280: 278-280. DOI: 10.1001/jama.280.3.278
[32]	Shojania KG, Sampson M, Ansari MT, et al. How quickly do systematic reviews go out of date? A survival analysis[J]. Ann Intern Med, 2007, 147: 224-233. DOI: 10.7326/0003-4819-147-4-200708210-00179
[33]	靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J]. 解放军医学杂志, 2020, 45: 1-20. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202001002.htm Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. Jiefangjun Yixue Zazhi, 2020, 45: 1-20. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202001002.htm
[34]	Dagens A, Sigfrid L, Cai E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the COVID-19 pandemic: rapid review[J]. BMJ, 2020, 369: m1936. http://www.bmj.com/content/369/bmj.m1936
[35]	Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines[J]. BMJ, 2016, 352: i1152. http://www.ncbi.nlm.nih.gov/pubmed/26957104
[36]	World Health Organization. WHO handbook for guideline development. 2nd edition[M/OL ]. [2020-12-09]. https://apps.who.int/iris/handle/10665/145714.
[37]	Garritty CM, Norris SL, Moher D. Developing WHO rapid advice guidelines in the setting of a public health emergency[J]. J Clin Epidemiol, 2017, 82: 47-60. DOI: 10.1016/j.jclinepi.2016.08.010
[38]	World Health Organization. Rapid risk assessment of acute public health events[EB/OL ]. [2020-12-09]. https://www.who.int/csr/resources/publications/HSE_GAR_ARO_2012_1/en/.
[39]	World Health Organization. Emergency Response Framework (ERF)[EB/OL]. [2020-12-09]. https://www.who.int/hac/about/erf/en/.
[40]	Kowalski SC, Morgan RL, Falavigna M, et al. Develop-ment of rapid guidelines: 1. Systematic survey of current practices and methods[J]. Health Res Policy Syst, 2018, 16: 61. DOI: 10.1186/s12961-018-0327-8
[41]	The BMJ. BMJ Rapid Recommendations[EB/OL ]. (2020-12-17)[2020-12-30]. https://www.bmj.com/rapid-recommendations.
[42]	Rochwerg B, Agarwal A, Zeng L, et al. Remdesivir for severe COVID-19: a clinical practice guideline[EB/OL ]. (2020-07-30)[2020-12-30]. https://www.bmj.com/content/370/bmj.m2924.
[43]	National Institutes of Health. COVID-19 treatment guidelines[EB/OL ]. (2020-11-27)[2020-12-30]. https://www.covid19treatmentguidelines.nih.gov/whats-new/.
[44]	Up to Date. Coronavirus disease 2019 (COVID-19): management in hospitalized adults[EB/OL ]. (2020-11-27)[2020-12-30]. https://www.uptodate.com/contents/coronavirus-disease-2019-COVID-19-management-in-hospitalized-adults.
[45]	Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19-Final Report[J]. N Engl J Med, 2020, 383: 1813-1826. DOI: 10.1056/NEJMoa2007764
[46]	Lamontagne F, Agoritsas T, Macdonald H, et al. A living WHO guideline on drugs for COVID-19[EB/OL ]. (2020-09-04)[2021-02-02]. https://www.bmj.com/content/370/bmj.m3379.
[47]	World Health Organization. Corticosteroids for COVID-19: living guidance[EB/OL ]. (2020-09-02)[2021-02-02]. https://apps.who.int/iris/handle/10665/334125.
[48]	Graham R, Mancher M, Wolman DM, et al. Clinical practice guidelines we can trust[M]. Washington DC: the National Academies Press, 2011.
[49]	Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. Introduction-the why, what, when, and how[J]. J Clin Epidemiol, 2017, 91: 23-30. DOI: 10.1016/j.jclinepi.2017.08.010
[50]	Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews: 2. Combining human and machine effort[J]. J Clin Epidemiol, 2017, 91: 31-37. DOI: 10.1016/j.jclinepi.2017.08.011
[51]	Simmonds M, Salanti G, McKenzie J, et al. Living Systematic Review Network. Living systematic reviews: 3. Statistical methods for updating meta-analyses[J]. J Clin Epidemiol, 2017, 91: 38-46. DOI: 10.1016/j.jclinepi.2017.08.008
[52]	Akl EA, Meerpohl JJ, Elliott J, et al. Living Systematic Review Network. Living systematic reviews: 4. Living guideline recommendations[J]. J Clin Epidemiol, 2017, 91: 47-53. DOI: 10.1016/j.jclinepi.2017.08.009
[53]	许吉, 邓宏勇. 动态系统评价简介[J]. 中国循证医学杂志, 2020, 20: 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202002018.htm Xu J, Deng HY. A brief introduction of living systematic review[J]. Zhongguo Xunzheng Yixue Zazhi, 2020, 20: 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202002018.htm
[54]	张迁, 王琪, 后亮瑛, 等. 动态指南制订方法及案例介绍[J]. 中国循证医学杂志, 2021, 21: 491-496.
[55]	MAGIC. Our approach[EB/OL ]. (2020-12-11)[2020-12-11]. https://magicevidence.org/approach/.

[1]	LU Yao, ZHANG Qian, CHENG Qianji, LIU Jianing, SUN Mingyao, NING Jinling, HUANG Jiajie, REN Simeng, ZHANG Wenzheng, LIU Yajie, DENG Xiyuan, TIAN Jinhui, LIU Jie, GE Long. Method for Developing Patient Decision Aid in China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1422-1431. DOI: 10.12290/xhyxzz.2023-0608
[2]	ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
[3]	LAI Honghao, SUN Mingyao, LI Ying, HUANG Jiajie, LIU Jianing, PAN Bei, TIAN Jinhui, GE Long. Vitruvian Plot: A Visual Tool for Intuitive Display of Evidence Summarization Results[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 668-675. DOI: 10.12290/xhyxzz.2023-0201
[4]	LU Yao, LIU Jianing, WANG Mian, HUANG Jiajie, HAN Baojin, SUN Mingyao, CHENG Qianji, NING Jinling, GE Long. Artificial Intelligence in Shared Decision Making[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 661-667. DOI: 10.12290/xhyxzz.2023-0209
[5]	TIAN Chen, YANG Qiuyu, SUN Mingyao, LIU Jie, TIAN Jinhui, CHEN Yaolong, YANG Kehu, GE Long. Methods for Developing Rapid and Living Evidence-based Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 183-191. DOI: 10.12290/xhyxzz.2023-0191
[6]	TIAN Chen, YANG Shuihua, YANG Kehu, GE Long. Constructed the Global Health Policy and Management Evidence Clearinghouse to Facilitate Evidence-based Policymaking and Health Governance for Sustainable Development[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0763
[7]	LIU Wanrong, TANG Hui, ZHOU Na, QIU Wei, LI Xiaoyuan, WANG Xiang, BAI Chunmei, ZHOU Jianfeng, ZHAO Lin. Incidence of COVID-19 in Patients with Tumor During the Omicron Pandemic[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1238-1245. DOI: 10.12290/xhyxzz.2023-0281
[8]	Yuan ZHANG. Patient Preference and Shared Decision Making[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 679-684. DOI: 10.3969/j.issn.1674-9081.2019.06.022
[9]	Xiao-qing LIU, Dong WU. Discipline Construction of Clinical Epidemiology and Evidence-based Medicine:What, Who, Where, and Whither?[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 398-402. DOI: 10.3969/j.issn.1674-9081.2019.04.017
[10]	Xia HONG. Shared Decision Making[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 277-280. DOI: 10.3969/j.issn.1674-9081.2018.03.016

Cited By

Cited by

Periodical cited type(1)

邹吉宇，王天娇，臧凝子，刘勇明，庞立健，王琳琳，吕晓东. 慢性阻塞性肺疾病发病机制及中药调节作用研究进展. 中国实验方剂学杂志. 2025(01): 287-298 .

Other cited types(1)

Get Citation

PDF

XML

Article Metrics

Article views (377) PDF downloads (42) Cited by(2)

Address：	Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
Tel：	010-69154261/4262
E - mail：	medj@pumch.cn mjpumch@126.com
Copyright of website：	Editorial Office of Medical Journal of Peking Union Medical College Hospital

Thinking about the Development of Rapid Recommendation Based on the Status of COVID-19 Evidence

Abstract

References

Related Articles

Cited by

Periodical cited type(1)

Other cited types(1)

Catalog

Article Metrics

Related

Thinking about the Development of Rapid Recommendation Based on the Status of COVID-19 Evidence

Abstract

References

Related Articles

Cited by

Periodical cited type(1)

Other cited types(1)

Catalog

Article Metrics

Related

Export File

Citation

Format

Content